Form D · Biotechnology
Pfenex Inc.
San Diego, CA · CIK 0001478121
Offering snapshot reported Dec 9, 2009 · SEC filing
- Reported sold
- $24M Offering amount: $24M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 1, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 9, 2009 | Initial | $24,000,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-136790
Issuer offered and sold a total of $130,900 worth of Common Stock, $14,000,000 worth of Series A-1 Participating Preferred Stock and $9,869,100 worth of Series A-2 Participating Preferred Stock, to accredited investors.
Source: Form D, filed Dec 9, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| James Gale | Director |
| Albert Hansen | Director |
| Bertrand C. Liang | Director, Executive |
| Dennis Merens | Director |
| Charles H. Squires | Executive |
| Henry Talbot | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
5501 Oberlin Drive
San Diego, CA, 92121
San Diego, CA, 92121